CDT Equity Inc. (CDT)
CDT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CDT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001896212 |
Financials
Not reported in SEC XBRL data.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt regarding the Company's ability to continue as a going concern for at least the next 12 months from the financial statement filing date." | 10-Q 2026-08-12 |
| Cash and burn | $747K cash; operating cash flow -$2.9M a quarter. | Report 2026-06-30 |
| Shares outstanding | 1,573,340 (2026-08-12); 3,062,025,000 a year earlier; 72,813,776,000 three years earlier. 1y figure adjusted for splits (1-for-2000 overall); 3y figure adjusted for splits (1-for-3000000 overall). | Cover page 2026-08-12 |
| Reverse splits, 3 years | 7; latest 1-for-20 on 2026-11-06 | Source 2026-11-06 |
| Shelf and offerings, 12 months | 2 S-3/F-3 shelf filings; 1 424B5 takedowns | Latest 2026-04-02 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-05-28 |
| Auditor | CBIZ CPAs P.C., New York, New York, United States; changed auditors 2 times in 24 months | 8-K 4.01 2026-06-29 |
| Late filings, 12 months | 2 NT notices | NT 10-Q 2026-05-15 |
| Insider trades, 12 months | Bought $0, sold $2.9M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
| Market cap check | The listing's market cap implies 1,017,862 shares at the 2026-11-13 price; the latest SEC cover count is 1,573,340 as of 2026-08-12, 1,573,340 after the 1-for-25 and 1-for-20 splits since. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page. | Nasdaq screener and SEC cover page |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | Not filed | -$4.6M | -$544K | $747K | No debt tags | Needs four quarters | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | Not filed | -$4.1M | -$1.9M | $97K | No debt tags | Needs four quarters | 10-Q 2026-07-15 |
| Q4 2025 2025-12-31 | Not filed | -$21.3M | -$4.6M | $1.5M | No debt tags | Needs four quarters | 10-K 2026-04-15 |
| Q3 2025 2025-09-30 | Not filed | -$7.1M | -$4.4M | $3.8M | No debt tags | Needs four quarters | 10-Q 2025-11-13 |
| Q2 2025 2025-06-30 | Not filed | -$6.0M | -$2.6M | $3.3M | No debt tags | Needs four quarters | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | Not filed | -$4.8M | -$3.9M | $2.1M | No debt tags | Needs four quarters | 10-Q 2026-07-15 |
| Q4 2024 2024-12-31 | Not filed | -$2.4M | -$3.8M | $554K | $1.8M | Needs four quarters | 10-K 2026-04-15 |
| Q3 2024 2024-09-30 | Not filed | -$6.5M | -$2.0M | $71K | $2.5M | Needs four quarters | 10-Q 2025-11-13 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.
Price moves
| Window | Return |
|---|---|
| 1 week | -69.5% |
| 1 month | -95.6% |
| 3 months | -100.0% |
| Year to date | -100.0% |
| 1 year | -100.0% |
| From 52-week high | -100.0% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| CDTTW | CDT Equity Inc. Warrant | $0.0070 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $0.2194 | -22.31% | $520K |
| SPRC | SciSparc Ltd. | $0.3307 | -10.62% | $815K |
| OGEN | Oragenics Inc. | $0.1980 | -1.49% | $893K |
| MTNB | Matinas Biopharma Holdings Inc. | $0.9270 | +3.00% | $908K |
| GOVX | GeoVax Labs Inc. | $2.02 | +18.48% | $1.1M |
| BDRX | Biodexa Pharmaceuticals plc American Depositary Shs | $2.24 | -6.28% | $1.2M |
| ELAB | PMGC Holdings Inc. | $1.66 | +5.06% | $1.3M |
| KAPA | Kairos Pharma Ltd. | $0.4069 | -10.30% | $1.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier